Moda Assurance Co. v. New Life Treatment Center

District Court, D. Alaska·Decided July 2, 2024·No. 3:23-cv-00132·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF ALASKA

MODA HEALTH PLAN, INC.,

Plaintiff, v. Case No. 3:23-cv-00132-SLG NEW LIFE TREATMENT CENTER,

Defendant.

ORDER RE DEFENDANT’S MOTION TO DISMISS AMENDED COMPLAINT

Before the Court at Docket 27-3 is Defendant New Life Treatment Center’s (“New Life”) “Motion to Dismiss Amended Complaint under Fed. R. Civ. P. 12(b)(1), (b)(2), (b)(3), and (b)(6); or in the alternative to transfer under 28 U.S.C. § 1404 to the Central District of California.”1 Plaintiff Moda Health Plan, Inc. (“Moda”) responded in opposition at Docket 30, to which New Life replied at Docket 32. Oral argument was not requested and was not necessary to the Court’s decision. BACKGROUND Moda is a health insurance company and Alaska corporation with its principal place of business in Anchorage, Alaska.2 It brings this suit against New

1 The Court granted New Life’s motion for leave to file the instant late motion to dismiss and accepted the motion to dismiss as filed at Docket 27-3. See Docket 29. While New Life included in the title of its motion the request to transfer the case to the Central District of California in the alternative, neither party discusses transferring the case in the briefing. Accordingly, the Court does not address any argument to that effect here. 2 Docket 26 at ¶ 14. Life, a substance abuse treatment center and California corporation with its principal place of business in California.3 Moda’s First Amended Complaint

asserts that “New Life orchestrated a deceptive and unlawful scheme through which it intentionally misrepresented Alaskans’ income to sign them up for Moda health insurance plans,” the result of which “has been fraudulent claims [against Moda] of approximately $3.3 million.”4 The complaint alleges that “Moda has so far paid an estimated $650,000 in claims (of a total of $3.3 million in claims for

which New Life has so far sought payment from Moda) for individuals whose health insurance applications contained information that New Life falsified or caused to be falsified.”5 The complaint asserts that “New Life purchased advertisements on social- media websites like Facebook and Instagram” that “were geographically targeted, included to users residing in Alaska.”6 It alleges that New Life’s alleged scheme

was propelled by an Alaska regulation, Title 3 of the Alaska Administrative Code (“AAC”), § 26.110(a), which “provides that private health care insurers must pay claims for healthcare services based on an amount that is equal to or greater than the 80th percentile of charges in a geographical area” (the “80th percentile rule”).7

3 See Docket 26 at ¶¶ 15, 20. 4 Docket 26 at ¶ 1. 5 Docket 26 at ¶ 58. 6 Docket 26 at ¶ 2. 7 Docket 26 at ¶¶ 32-33. The complaint explains that “[t]he effect of Alaska’s 80th percentile rule is that out- of-network providers like New Life receive a much higher payment from private

health insurers like Moda than they would from (a) private insurers in states without such a rule; and (b) public insurers like Medicaid.”8 It alleges that “New Life, or its employees or agents, purposefully availed itself of the privilege of conducting business in Alaska by inducing Alaska residents to seek treatment for substance abuse at its treatment center, and by enrolling them in an Alaskan health insurance

plan offered by Moda through the health insurance exchange, thereby invoking the benefits and protections of Alaska law.”9 The complaint further asserts that, “[o]nce enrolled in a Moda health plan, New Life’s patient advocates purchased their recruits’ plane tickets for the journey from Alaska to New Life’s treatment center in California.”10 The complaint alleges jurisdiction based on diversity of citizenship and contains three causes of action: (1) fraud/intentional

misrepresentation under Alaska law; (2) negligent misrepresentation under Alaska law; and (3) civil conspiracy under Alaska law.11 Prior to Moda’s First Amended Complaint, New Life had filed a motion to dismiss Moda’s initial complaint, asserting that: Moda lacked standing; the Court

8 Docket 26 at ¶ 34. 9 Docket 26 at ¶ 18. 10 Docket 26 at ¶ 40. 11 Docket 26 at ¶¶ 60-77. lacked personal jurisdiction over New Life; the District of Alaska was not the appropriate venue; and that Moda had failed to state a claim upon which relief could be granted.12 Moda then filed a motion to amend its complaint which New

Life opposed, asserting that any amendment would be futile for the same reasons stated in its motion to dismiss.13 The Court allowed Moda to amend its complaint and denied New Life’s motion to dismiss but without prejudice to its renewal after Moda filed an amended complaint.14 New Life subsequently filed the instant

motion to dismiss, raising most of the same arguments in its previous motion to dismiss and asserting that: Moda lacks standing; the Court lacks personal jurisdiction over New Life; Moda’s First Amended Complaint fails to state a claim upon which relief can be granted; and amendment would be futile.15 In support of its motion, New Life attached the declaration of its Chief Executive Officer (“CEO”), John Malek.16 In the declaration, Mr. Malek states that “New Life does not target

any particular state or residents of any particular state,” but “[i]t does advertise more extensively in states that happen to be closer to California or otherwise lack treatment center options for residents.”17 Mr. Malek also states that before this

12 See Docket 12 at 3. 13 Docket 18; Docket 21. 14 Docket 25 at 18-19. 15 Docket 27-3 at 3. 16 Docket 27-4. 17 Docket 27-4 at ¶¶ 15, 18. action was filed, “New Life was not aware of the Alaska statute referred to in the Complaint as the Alaska 80th percentile rule” and hence, “did not target Alaska- resident patients based on this statute.”18

DISCUSSION The Court addresses in turn each of the grounds on which New Life asserts Moda’s First Amended Complaint should be dismissed pursuant to Federal Rule of Procedure 12(b).

I. Rule 12(b)(1) – Standing A lack of standing necessitates dismissal under Federal Rule of Civil Procedure 12(b)(1). Standing requires a plaintiff to show (1) an injury in fact, meaning an “invasion of a legally protected interest that is (a) concrete and particularized, and (b) actual or imminent, not conjectural or hypothetical”; (2) causation; and (3) redressability, meaning that “the injury will likely be redressed

by a favorable decision.”19 Similar to its previous opposition to Moda’s motion to amend its complaint, New Life contends that Moda has not alleged that it suffered an injury in fact because Moda paid “legitimate claims at a statutory rate” under Alaska law and that, “[a]t best, Moda’s new theory alleges a harm to the government only.”20 New Life further contends that Moda “lacks standing due to

18 Docket 27-4 at ¶ 19. 19 Townley v. Miller, 722 F.3d 1128, 1133 (9th Cir. 2013) (citing Lujan v. Defs. of Wildlife, 504 U.S. 555, 560-61 (1992)). 20 Compare Docket 27-3 at 15-16, with Docket 21 at 11-12. lack of causation or redressability” because “[a]ny alleged misreported income does not cause New Life’s patients to become Moda-insured or receive treatment

Free access — add to your briefcase to read the full text and ask questions with AI

Moda Assurance Co. v. New Life Treatment Center, (D. Alaska 2024).

Moda Assurance Co. v. New Life Treatment Center (Moda Assurance Co. v. New Life Treatment Center) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Wendy Townley v. Ross Miller
722 F.3d 1128 (Ninth Circuit, 2013)
Schwarzenegger v. Fred Martin Motor Co.
374 F.3d 797 (Ninth Circuit, 2004)
Herbal Brands, Inc. v. Photoplaza, Inc.
72 F.4th 1085 (Ninth Circuit, 2023)
Jane Doe v. Webgroup Czech Republic, A.S.
93 F.4th 442 (Ninth Circuit, 2024)